These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38899369)

  • 1. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A
    Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
    Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
    Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
    Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
    Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor.
    Liu S; Chen H; Wu Q; Sun Y; Pei Y; Wang Z; Zhu D; Li G; Bryce MR; Chang Y
    Inorg Chem; 2024 Sep; 63(35):16404-16417. PubMed ID: 39150967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Photodynamic and Photochemotherapeutic Platinum-Iridium Charge-Transfer Conjugate for Anticancer Therapy.
    Shi H; Carter OWL; Ponte F; Imberti C; Gomez-Gonzalez MA; Cacho-Nerin F; Quinn PD; Parker JE; Sicilia E; Huang H; Sadler PJ
    Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202400476. PubMed ID: 38656762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
    Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
    J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy.
    Wang W; Wang L; Zhang Y; Shi Y; Zhang R; Chen L; Shi Z; Yuan S; Li X; He C; Li X
    Inorg Chem; 2024 Apr; 63(17):7792-7798. PubMed ID: 38619892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z; Lin M; Liu J; Wu H; Chao H
    Dalton Trans; 2024 Aug; 53(31):12917-12926. PubMed ID: 39028267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
    Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosome-targeted cyclometalated Ir(III) complexes as photosensitizers/photoredox catalysts for cancer therapy.
    Chen Y; Liang C; Kou M; Tang X; Ru J
    Dalton Trans; 2024 Jul; 53(28):11836-11849. PubMed ID: 38949269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.
    Roque JA; Barrett PC; Cole HD; Lifshits LM; Bradner E; Shi G; von Dohlen D; Kim S; Russo N; Deep G; Cameron CG; Alberto ME; McFarland SA
    Inorg Chem; 2020 Nov; 59(22):16341-16360. PubMed ID: 33126792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.